Lotus Health Group Company EBIT

The latest EBIT for 600186.SS is $500M as of June 2026. That compares with $400M in the prior-year period — up 23.0% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Lotus Health Group Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, 600186.SS's EBIT moved from $400M to $500M — a 23.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lotus Health Group Company's operating scale or balance-sheet position.

Against its sector companies, 600186.SS currently prints $500M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Lotus Health Group Company's growth, margins, and balance sheet.

A EBIT figure of $500M for 600186.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 600186.SS's EBIT ($500M), review year-over-year change from $400M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.